EntreMed received notice that it will lose its NASDAQ listing unless it boosts its share price above $1 between now and Oct. 1. The NASDAQ exchange has warned the Rockville cancer drug company that …
Leave a Comment
EntreMed received notice that it will lose its NASDAQ listing unless it boosts its share price above $1 between now and Oct. 1. The NASDAQ exchange has warned the Rockville cancer drug company that …